
    
      A mono-center, open, randomized, three-way, twelve-sequence, cross-over study to determine
      the extent of absorption (absolute bioavailability), rate of absorption and to further
      characterize distribution and elimination characteristics of a commercial 250 mg and a 500 mg
      capsule of flucloxacillin each given as a single oral dose vs. one 250 or 500 mg intravenous
      dose to 24 healthy male and/or female subjects in the fasting state
    
  